The impact of metformin use on the outcomes of locally advanced breast cancer patients receiving neoadjuvant chemotherapy: an open-labelled randomized controlled trial

Recently, several clinical trials have attempted to find evidence that supports the anticancer use of metformin in breast cancer (BC) patients. The current study evaluates the anticancer activity of metformin in addition to neoadjuvant chemotherapy (NACT) in locally advanced BC patients. Additionall...

Descripción completa

Detalles Bibliográficos
Autores principales: Barakat, Hadeer Ehab, Hussein, Raghda R. S., Elberry, Ahmed Abdullah, Zaki, Mamdouh Ahmed, Ramadan, Mamdouh Elsherbiny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091204/
https://www.ncbi.nlm.nih.gov/pubmed/35538143
http://dx.doi.org/10.1038/s41598-022-11138-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091204/
https://www.ncbi.nlm.nih.gov/pubmed/35538143
http://dx.doi.org/10.1038/s41598-022-11138-3

Ejemplares similares